長航鳳凰(000520.SZ)漲超5% 獲南燁集團三度舉牌 持股逼近第一大股東
格隆匯12月18日丨長航鳳凰(000520.SZ)漲5.59%,報4.53元,暫成交8045萬元,最新總市值45.85億元。
繼9月份二次舉牌後,南燁集團並未停止增持的腳步。公司昨晚公告,南燁集團及一致行動人從今年9月27日至12月17日通過集中競價和大宗交易增持長航鳳凰,目前南燁集團及一致行動人的合計持股比例已從10%增至15%,達到第三次舉牌,進一步逼近公司第一大股東順航海運17.89%的持股比例。
有分析人士認為,南燁集團連續舉牌,或是為了公司控制權而來。公司第一大股東順航海運持有上市公司1.81億股股份,占上市公司總股本的17.89%,已全部凍結。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.